Evidence map›Paper›PMID 36208170›Full record

ArticleJournal of biomedical materials research. Part B, Applied biomaterials2023

Syndecan-4 and stromal cell-derived factor-1 alpha functionalized endovascular scaffold facilitates adhesion, spreading and differentiation of endothelial colony forming cells and functions under flow and shear stress conditions.

Yidi Wu, Saami K Yazdani, Johanna Elin Marie Bolander, William D Wagner

Open access · hybridAbstract read
In one paragraph

Article in Journal of biomedical materials research. Part B, Applied biomaterials, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Recent Advances in Silk Fibroin Derived fromJournal of functional biomaterials · 2025
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Yidi WuDepartment of Plastic and Reconstructive Surgery, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Saami K YazdaniDepartment of Engineering, Wake Forest University, Winston-Salem, North Carolina, USA.
Johanna Elin Marie BolanderWake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, North Carolina, USA.
William D WagnerDepartment of Plastic and Reconstructive Surgery, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Virginia Tech - Wake Forest University School of Biomedical Engineering & Sciences · USForest Institute · USWake Forest University · US

Funding

Local delivery of smooth muscle cell targeted aptamer to inhibit neointimal growth and accelerate vascular healingR01EB028798 · NIBIB · WAKE FOREST UNIVERSITY · PI YAZDANI, SAAMI K · 2020 to 2023
$1.9M
NIBIB NIH HHS R01 EB028798
6 · The paper itself

Abstract

Acellular vascular scaffolds with capture molecules have shown great promise in recruiting circulating endothelial colony forming cells (ECFCs) to promote in vivo endothelialization. A microenvironment conducive to cell spreading and differentiation following initial cell capture are key to the eventual formation of a functional endothelium. In this study, syndecan-4 and stromal cell-derived factor-1 alpha were used to functionalize an elastomeric biomaterial composed of poly(glycerol sebacate), Silk Fibroin and Type I Collagen, termed PFC, to enhance ECFC-material interaction. Functionalized PFC (fPFC) showed significantly greater ECFCs capture capability under physiological flow. Individual cell spreading area on fPFC (1474 ± 63 μm

Indexed as

Chemokine CXCL12Endothelial CellsSyndecan-4Cell DifferentiationCells, CulturedNeovascularization, PhysiologicChemokine CXCL12Syndecan-4

Identifiers

PMID36208170
PMCPMC10092721
OpenAlexW4303647051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.